Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients
Clinical trial NCT04672564 · TERMINATED
Trial details
- NCT number
- NCT04672564
- Sponsor
- Shenyang Tonglian Group CO., Ltd
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-30
- Primary completion
- 2022-03-24
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.